. 2016 Mar 13;2016:7896081. doi: 10.1155/2016/7896081

Table 1.

Homogeneity test for general characteristics and measurement variables.

Characteristics or variables	Placebo (N = 27)	Aromatherapy (N = 27)	Total (N = 54)	P value
Age (year)	30.852 ± 11.302	28.889 ± 9.010	29.870 ± 10.172	0.652^∗
TNSS (score)
Overall	6.444 ± 2.532	6.815 ± 2.202	6.630 ± 2.358	0.569
Sneeze	1.481 ± 0.753	1.519 ± 0.580	1.500 ± 0.666	0.885^a
Runny nose	1.852 ± 0.864	1.815 ± 0.736	1.833 ± 0.795	0.825^a
Itchy nose	1.630 ± 0.792	1.630 ± 0.839	1.630 ± 0.808	0.244^a
Nose obstruction	1.556 ± 0.801	1.852 ± 0.818	1.704 ± 0.816	0.969^a
RQLQ (score)
Overall	1.903 ± 0.614	1.870 ± 0.561	1.887 ± 0.583	0.837
Activity limitation	2.605 ± 0.925	2.568 ± 0.772	2.586 ± 0.844	0.924
Sleep problems	1.778 ± 1.013	1.728 ± 1.004	1.753 ± 0.999	0.972^a
Nose symptoms	2.630 ± 0.861	2.639 ± 0.606	2.634 ± 0.738	0.957
Eye symptoms	1.852 ± 1.057	1.574 ± 0.914	1.713 ± 0.989	0.310
Non nose/eye symptoms	2.185 ± 0.814	1.984 ± 0.743	2.085 ± 0.778	0.390
Practical problems	1.062 ± 0.722	1.358 ± 0.852	1.210 ± 0.796	0.180
Emotional function	0.935 ± 0.903	1.167 ± 0.893	1.051 ± 0.897	0.386
VSH scale (score)	38.570 ± 11.598	42.159 ± 10.025	40.365 ± 10.889	0.229
CFS (score)	33.481 ± 7.678	35.000 ± 7.000	34.241 ± 7.317	0.451

TNSS, total nasal symptoms score; RQLQ, Rhinoconjunctivitis quality of life questionnaire; VSH, Verran Synder-Halpern; CFS, Chalder fatigue scale.

Data reported as mean ± standard deviation.

Student's 2-sample t-test. ^aMann-Whitney U test.